In this issue:
- Digestive impairment in systemic sclerosis
- Adverse event-related JAK inhibitor and biologic DMARD discontinuations in RA
- RANKL blockade for erosive hand OA
- Achieving serum urate goals in gout
- Body mass and adiposity associated with response to RA treatment strategies
- EHR-integrated app for RA PROs
- Predictors of organ damage in SLE in Asia-Pacific
- Tocilizumab or abatacept injection spacing in RA in remission
- Adverse CV events in JAK inhibitor-treated RA
- Etanercept originator vs. biosimilar in RA
Please login below to download this issue (PDF)